Helping you make wiser investment decisions

Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition

March 18, 2022 kdunleavy



Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition
kdunleavy
Fri, 03/18/2022 – 18:13



Source link